跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAR-PALIPERIDONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAR-PALIPERIDONE
Authorized
STANDARD
MAR-PALIPERIDONE
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5dd2875eb4430f54
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
5dd2875eb4430f54
Drug Approval Canada Name
MAR-PALIPERIDONE
Product Name
MAR-PALIPERIDONE
Status
Dormant
Status Date
2021-11-01
Original Market Date
2021-06-29
Din
02511010
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AX13 PALIPERIDONE
Atc Name
n 05 ax 13
Aig Number
0152320001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
PALIPERIDONE
3 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5dd2875eb4430f54
Type
Standard
Back to Health Canada Approvals